Source-grounded facts extracted from Lantheus Holdings, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Minnie Baylor-Henry was appointed as Director at Lantheus Holdings, Inc..
“On March 1, 2022, Lantheus Holdings, Inc. (“Lantheus”) appointed Ms. Minnie Baylor-Henry, a renowned expert in regulatory affairs and compliance in the life sciences industry, to Lantheus’ Board of Directors (the “Board”).”
Istvan Molnar resigned as Chief Medical Officer at Lantheus Holdings, Inc..
“On October 13, 2021, Dr. Istvan Molnar informed Lantheus Holdings, Inc. (the “ Compan y”) of his resignation as the Chief Medical Officer of the Company and its subsidiaries, effective as of October 13, 2021.”
Robert J. Marshall, Jr. changed role as principal accounting officer at Lantheus Holdings, Inc..
“Robert J. Marshall, Jr., the Company’s Chief Financial Officer and principal financial officer, will no longer serve as principal accounting officer of the Company as of the Effective Date.”
Andrea Sabens was appointed as principal accounting officer at Lantheus Holdings, Inc..
“On July 21, 2021, the Board of Directors of the Company appointed Andrea Sabens as the principal accounting officer of the Company and its subsidiaries, effective July 21, 2021 (the “ Effective Date ”).”
John Bolla resigned as Chief Operations Officer at Lantheus Holdings, Inc..
“On July 19, 2021, John Bolla informed Lantheus Holdings, Inc. (the “ Company”) of his intention to resign as the Chief Operations Officer of the Company and its subsidiaries, effective as of August 6, 2021 to pursue other opportunities.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.